Center for Allergy and Asthma of Georgia Contacts Patients Regarding Auvi-Q Recall

Recently, a global healthcare company, Sanofi, announced a recall of their epinephrine injection products called Auvi-Q. According to many reports, some of these devices contain inaccurate dosages of medication, which poses potential danger to those relying on such products as a source of emergency relief when suffering severe allergic reactions.

As of October 26th, 26 people reported device malfunctions. Although there were no fatalities involved, the risk for harm remains severe.

If you possess an Auvi-Q product with any of the following qualifications, you may be eligible to return your product as a recall:

  • The number of the product is between 2081278 and 3037230
  • The product expires between October 2015 and December 2016
  • The dosage of the product reads 0.15mg or 0.3mg

Center for Allergy and Asthma of Georgia is Eager to Help

Once Sanofi released information about the potential dangers of this product, our Atlanta allergists from the Center for Allergy and Asthma of Georgia began urgently contacting patients, via texts and emails, who had been prescribed this device. To immediately safeguard the health of patients, the team prescribed alternate forms of medication in the form of epi pens.

As a result, many individuals who were at risk for allergy-related emergencies were successfully notified and cared for.

Have You Been Prescribed Auvi-Q?

Whether you are a former or new patient of the Center for Allergy and Asthma of Georgia, we can help you find an alternate medication in place of the Auvi-Q epi pen. Furthermore, when you choose to work with our team, we can take the time to understand your condition and develop a care plan to ensure you are as healthy and happy as possible.

Don’t wait! Start feeling your best by contacting our Atlanta allergists today.

Previous Post Next Post
Blog search